Palero, Celestino .

HRN: 17-42-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2026
CO-AMOXICLAV 625MG (TAB)
04/12/2026
04/18/2026
PO
625mg
BID
Soft Tissue Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines